retatrutide
PulseAugur coverage of retatrutide — every cluster mentioning retatrutide across labs, papers, and developer communities, ranked by signal.
3 day(s) with sentiment data
-
Eli Lilly drug shows sleep apnea benefits; T-Mobile launches T-Mix
Two separate technology companies have made recent announcements. Eli Lilly and Company has revealed that their obesity drug, retatrutide, has shown significant benefits in reducing sleep apnea episodes during trials. S…
-
Lenovo Googlebook 15 Review and Retatrutide Black Market Dangers
This cluster contains two unrelated news items: one reviewing the Lenovo Googlebook 15 laptop and discussing the drawbacks of early adoption, and another detailing the dangers of the black market for the unapproved weig…
-
GLP-1 drugs poised to outpace AI in impact and revenue
GLP-1 drugs are projected to have a more significant impact than artificial intelligence over the next two years, with sales expected to surpass generative AI revenue by the end of 2025. While initial costs were high, p…
-
Eli Lilly escalates fight against black market retatrutide
Eli Lilly & Co. is intensifying its efforts to combat the illicit market for retatrutide, an experimental weight-loss drug. The company has filed lawsuits against businesses in the US, particularly in Texas, that are il…
-
Eli Lilly's Obesity Drugs Fuel 48% Revenue Growth, Retatrutide Trials Show Promise
Eli Lilly and Company reported a significant increase in its second-quarter revenue, reaching $23 billion, a 48% year-over-year growth. This surge was primarily driven by its GLP-1 drugs, Mounjaro and Zepbound, which ge…